Senior insider sale
President and CEO at TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$2.32M
30K shares
What this filing means
AZAMIAN BOBAK R. plans to sell 30K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $2.32M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/4/2026ACC: 0001628280-26-060766
DirectorOfficer10% Owner· President and CEO
Since Oct 2020
30K
Shares to sell
$2.32M
Approx. market value
10K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
PRIVATE PLACEMENT
N/A
1/13/2017
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/13/2017 | PRIVATE PLACEMENT N/A | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
10K
Market value
$800.6K
9/2/2026
—Completed
Units to sell
10K
Market value
$615.5K
6/17/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
10K
Market value
$905.6K
9/4/2026
Total
Units
30K
Value
$2.32M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/2/2026 | 10K | $800.6K | — | Completed |
6/17/2026 | 10K | $615.5K | — | Completed |
| Planned — Approximate Date | ||||
9/4/2026 | 10K | $905.6K | NASDAQ | Planned |
| Total | 30K | $2.32M | ||